Femasys (FEMY) EBITDA Margin (QoQ) (2020 - 2025)
Femasys (FEMY) EBITDA Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 65,903.00 |
| Mar 31, 2025 | -78,808.00 |
| Dec 31, 2024 | 11,036.00 |
| Sep 30, 2024 | 110,130.00 |
| Jun 30, 2024 | -74,662.00 |
| Mar 31, 2024 | 81,082.00 |
| Dec 31, 2023 | -41,771.00 |
| Sep 30, 2023 | -75,416.00 |
| Jun 30, 2023 | 11,862.00 |
| Mar 31, 2023 | 24,623.00 |
| Dec 31, 2022 | -40,099.00 |
| Sep 30, 2022 | -233.00 |
| Jun 30, 2022 | 1,937.00 |
| Mar 31, 2022 | 3,013.00 |
| Dec 31, 2021 | -9,188.00 |
| Sep 30, 2021 | -25,202.00 |
| Jun 30, 2021 | -2,926.00 |
| Mar 31, 2021 | 3,854.00 |
| Dec 31, 2020 | -9,278.00 |
| Sep 30, 2020 | 31,006.00 |